𝔖 Bobbio Scriptorium
✦   LIBER   ✦

A cost-utility analysis of drug treatments in patients with HBeAg-positive chronic hepatitis B in Thailand

✍ Scribed by Tantai, Narisa; Chaikledkaew, Usa; Tanwandee, Tawesak; Werayingyong, Pitsaphun; Teerawattananon, Yot

Book ID
125400273
Publisher
BioMed Central
Year
2014
Tongue
English
Weight
413 KB
Volume
14
Category
Article
ISSN
1472-6963

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Comparison of interferon and lamivudine
Comparison of interferon and lamivudine treatment in Japanese patients with HBeAg positive chronic hepatitis B
✍ Yasuji Arase; Kenji Ikeda; Fumitaka Suzuki; Yoshiyuki Suzuki; Masahiro Kobayashi πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 117 KB πŸ‘ 1 views

## Abstract The aim of this study was to elucidate the long‐term outcome after interferon (IFN) or lamivudine (LMV) treatment in Japanese patients with hepatitis B e antigen (HBeAg) positive chronic hepatitis B. Inclusion criteria were biopsy proven chronic hepatitis or liver cirrhosis, no history